IL205061A0 - Compositions comprising semaphorins for the treatment of angiogensis related diseases and methods of selection thereof - Google Patents

Compositions comprising semaphorins for the treatment of angiogensis related diseases and methods of selection thereof

Info

Publication number
IL205061A0
IL205061A0 IL205061A IL20506110A IL205061A0 IL 205061 A0 IL205061 A0 IL 205061A0 IL 205061 A IL205061 A IL 205061A IL 20506110 A IL20506110 A IL 20506110A IL 205061 A0 IL205061 A0 IL 205061A0
Authority
IL
Israel
Prior art keywords
angiogensis
semaphorins
compositions
selection
treatment
Prior art date
Application number
IL205061A
Other versions
IL205061A (en
Original Assignee
Rappaport Family Inst For Res
Gera Neufeld
Boaz Kigel
Ofra Kessler
Asya Varshavsky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2008/001307 external-priority patent/WO2009050691A2/en
Application filed by Rappaport Family Inst For Res, Gera Neufeld, Boaz Kigel, Ofra Kessler, Asya Varshavsky filed Critical Rappaport Family Inst For Res
Priority to IL205061A priority Critical patent/IL205061A/en
Publication of IL205061A0 publication Critical patent/IL205061A0/en
Publication of IL205061A publication Critical patent/IL205061A/en

Links

IL205061A 2007-10-19 2010-04-13 Compositions comprising pro-protein convertase resistant semaphorins 3d, 3e and 3g for the treatment of angiogenesis related diseases and methods of selection thereof IL205061A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL205061A IL205061A (en) 2007-10-19 2010-04-13 Compositions comprising pro-protein convertase resistant semaphorins 3d, 3e and 3g for the treatment of angiogenesis related diseases and methods of selection thereof

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US96091007P 2007-10-19 2007-10-19
US649608P 2008-01-16 2008-01-16
US7105308P 2008-04-10 2008-04-10
US7156008P 2008-05-06 2008-05-06
PCT/IL2008/001307 WO2009050691A2 (en) 2007-10-19 2008-10-02 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
IL205061A IL205061A (en) 2007-10-19 2010-04-13 Compositions comprising pro-protein convertase resistant semaphorins 3d, 3e and 3g for the treatment of angiogenesis related diseases and methods of selection thereof

Publications (2)

Publication Number Publication Date
IL205061A0 true IL205061A0 (en) 2010-11-30
IL205061A IL205061A (en) 2014-05-28

Family

ID=43570489

Family Applications (1)

Application Number Title Priority Date Filing Date
IL205061A IL205061A (en) 2007-10-19 2010-04-13 Compositions comprising pro-protein convertase resistant semaphorins 3d, 3e and 3g for the treatment of angiogenesis related diseases and methods of selection thereof

Country Status (1)

Country Link
IL (1) IL205061A (en)

Also Published As

Publication number Publication date
IL205061A (en) 2014-05-28

Similar Documents

Publication Publication Date Title
EP2210092A4 (en) Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
EP2125855A4 (en) Methods and compositions for the treatment of cancer or other diseases
HK1144390A1 (en) Compositions for the treatment of neoplastic diseases
EP2041317A4 (en) Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases
EP2134363A4 (en) Compositions and methods for treatment of cervical cancer
EP2118074A4 (en) Compounds for the prevention and treatment of cardiovascular diseases
EP2212440A4 (en) Methods and compositions for the diagnosis and treatment of esphageal adenocarcinomas
EP2211881A4 (en) Compositions and methods for prevention and treatment of mammalian diseases
PT2056842E (en) Modified-galactosyl ceramide for the treatment of cancerous diseases
EP2049151A4 (en) Methods and compositions for the treatment of cancer
EP2217238A4 (en) Methods and compositions for the treatment of proteinuric diseases
HK1245679A1 (en) Methods and compositions for treating dermatological diseases and conditions
IL198723A0 (en) Methods and compositions for therapeutic treatment
EP2271352A4 (en) Compositions and methods for treatment of neoplastic disease
ZA200800448B (en) Methods and compositions for the prevention and treatment of inflammatory disease
ZA201200944B (en) Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
ZA201102442B (en) Compositions and methods for the treatment of bowel diseases with granulated mesalamine
HK1171677A1 (en) Composition for the treatment of hemorrhoids and related diseases
EP1858524A4 (en) Compositions and methods for treatment of autoimmune and related diseases
EP2150270A4 (en) Methods and compositions for the treatment of cancer
PL2234631T3 (en) Compounds and methods for the treatment of vascular disease
IL213703A (en) Compounds for the treatment of pain and other diseases
EP2170351A4 (en) Methods and compositions for treatment of cancer and other angiogenesis - related diseases
EP2096927A4 (en) Therapeutic compositions and methods of treatment with capsianoside-type compounds
EP2331092A4 (en) Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed